MDA Ltd.
MDALF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $0 |
| % Growth | 33.7% | 26% | 34.5% | – |
| Cost of Goods Sold | $1 | $1 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 26.1% | 30.2% | 35.6% | 35.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 9.9% | 9.6% | 11.6% | 3.9% |
| Other Income/Exp. Net | $0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 7.4% | 6% | 4.1% | 0.6% |
| EPS | 0.65 | 0.4 | 0.22 | 0.024 |
| % Growth | 62.5% | 81.8% | 801.6% | – |
| EPS Diluted | 0.64 | 0.4 | 0.21 | 0.024 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 21.3% | 19.1% | 22.6% | 25.9% |